Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma

Introduction: T cell checkpoint inhibitors targeting Programmed cell Death protein-1 (PD-1) have emerged as novel immunotherapy agents showing remarkable efficacy in head and neck squamous cell carcinoma (HNSCC). Despite important clinical benefits, they are associated with side effects that occur a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Spathas, Nikolaos, Economopoulou, Panagiota, Cheila, Myrto, Kotsantis, Ioannis, Fanouriakis, Antonis, Kassara, Dimitra, Psyrri, Amanda
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168664/
https://ncbi.nlm.nih.gov/pubmed/30319973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00409
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados